IRIS UniCatt

Agnes, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.265
NA - Nord America 4.909
AS - Asia 2.192
SA - Sud America 214
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 11
Totale 12.630
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.851
DE - Germania 1.851
CN - Cina 909
SE - Svezia 908
SG - Singapore 775
UA - Ucraina 597
IT - Italia 510
FR - Francia 295
IE - Irlanda 287
GB - Regno Unito 204
BR - Brasile 186
FI - Finlandia 186
PL - Polonia 160
ID - Indonesia 159
IN - India 91
RU - Federazione Russa 81
TR - Turchia 81
BE - Belgio 55
HK - Hong Kong 41
CA - Canada 37
IR - Iran 32
KR - Corea 25
JP - Giappone 23
NL - Olanda 22
AT - Austria 15
MX - Messico 15
LT - Lituania 14
CH - Svizzera 13
EU - Europa 13
CZ - Repubblica Ceca 11
AR - Argentina 9
AU - Australia 9
CI - Costa d'Avorio 9
ES - Italia 9
EC - Ecuador 7
PT - Portogallo 7
RO - Romania 7
VN - Vietnam 7
BG - Bulgaria 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
BD - Bangladesh 4
CL - Cile 4
DK - Danimarca 4
EE - Estonia 4
GR - Grecia 4
KG - Kirghizistan 4
LV - Lettonia 4
PH - Filippine 4
TH - Thailandia 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
CO - Colombia 3
KE - Kenya 3
MA - Marocco 3
MD - Moldavia 3
UZ - Uzbekistan 3
CY - Cipro 2
IL - Israele 2
IQ - Iraq 2
KH - Cambogia 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
PA - Panama 2
SA - Arabia Saudita 2
TW - Taiwan 2
VE - Venezuela 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KW - Kuwait 1
MU - Mauritius 1
NP - Nepal 1
PE - Perù 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
Totale 12.630
Salva come PNG Salva come JPEG
Città #
Chandler 979
Singapore 443
Ashburn 434
Jacksonville 338
Dublin 280
San Mateo 269
Ann Arbor 195
Nanjing 184
Jakarta 157
New York 125
Warsaw 123
Boston 118
Wilmington 118
Nürnberg 112
Woodbridge 111
Marseille 103
Beijing 100
Dearborn 91
Lawrence 89
Rome 89
Seattle 88
Bremen 82
Redwood City 81
Milan 78
Cattolica 76
Helsinki 74
Nanchang 69
Houston 68
Izmir 67
Moscow 60
Fairfield 57
Shenyang 57
Hangzhou 54
Munich 54
Princeton 53
Brussels 51
Chicago 51
Lancaster 47
Zhengzhou 45
Hebei 42
Frankfurt am Main 40
University Park 38
Los Angeles 37
Augusta 33
Detroit 33
Mountain View 33
Andover 32
Hong Kong 32
The Dalles 32
Changsha 28
Tianjin 28
Kunming 26
Norwalk 26
Shanghai 25
London 22
Boardman 20
Guangzhou 20
Düsseldorf 19
Jiaxing 19
Jinan 18
Kish 18
Chengdu 17
Nuremberg 17
Toronto 17
Cambridge 16
Leawood 16
Ningbo 16
Pune 15
São Paulo 15
Fremont 14
Hounslow 14
Lauterbourg 14
Kraków 13
North Bergen 12
San Giovanni Bianco 12
Santa Clara 11
Washington 11
Hefei 10
Portsmouth 10
Vienna 10
Abidjan 9
Hyderabad 9
Mexico City 9
Paris 9
San Diego 9
Segrate 9
Seongnam 9
Lanzhou 8
Santa Maria 8
Belo Horizonte 7
Buffalo 7
Mcallen 7
Ottawa 7
Seoul 7
Tokyo 7
Ardabil 6
Berlin 6
Brno 6
Falkenstein 6
Phoenix 6
Totale 6.702
Salva come PNG Salva come JPEG
Nome #
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 303
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. 237
Liver Transplantation in Alcoholic Patients: Impact of an Alcohol Addiction Unit Within a Liver Transplant Center 205
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 189
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.- 169
Duplex Doppler in the postoperative monitoring of liver transplant recipients 165
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 159
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant 159
Optimization of Donor-Recipient match and identification of the futile match cutoff. A national italian study on liver transplantation. 148
Use of an esophageal echo-Doppler device during liver transplantation: preliminary report 147
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 142
Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome 141
Lumbar chemical sympathectomy in end stage of arterial disease: early and late results 135
Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients 125
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 122
Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note 120
Comparative evaluation of two perfusion solutions for liver preservation and transplantation. 119
Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review 119
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center 116
Enzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis index 113
D-MELD, a strong and accurate tool to guide donor-2-recipient matching 113
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation 112
Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study 111
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 110
Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation 109
Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match 109
Model for end-stage liver disease dynamic stratification of survival benefit 108
Psychological risk factors for graft rejection among liver transplant recipients 107
Prediction of 6-month survival after liver transplantation using Cox regression. 106
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 106
Liver transplantation in patients with alcoholic liver disease: A retrospective study 105
Adipose tissue-derived mesenchymal stem cells and hepatic differentiation: old concepts and future perspectives 103
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 102
Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation 101
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 100
Psychological risk factors for graft rejection among liver transplant recipients 100
Fungal infections after liver transplantation: incidence and outcome 99
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 98
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 97
[Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience] 97
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association 97
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 96
Orpitt: a computerized chart for intraoperative real time management of liver transplant data 95
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 94
Donor risk index and organ patient index as predictors of graft survival after liver transplantation 92
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV patients. 91
Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation 91
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 91
Prediction of 6-month survival after liver transplantation using Cox regression 90
The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. 88
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 88
Anidulafungin--a new therapeutic option for Candida infections in liver transplantation 88
Intra-operative parathyroid hormone monitoring through central laboratory is accurate in renal secondary hyperparathyroidism. 88
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 87
Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note 87
Paradoxical effect of short-term protein loading on CsA-treated kidney transplant recipients 87
Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity 87
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 86
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 86
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 86
A Case of Insulinoma Detected by 68Ga-DOTANOC PET/CT and Missed by 18F-Dihydroxyphenylalanine PET/CT 86
Lamivudine-induced muscle mitochondrial toxicity 86
Overextended Criteria Donors: Experience of an Italian Transplantation Center 85
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 85
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 84
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 84
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center 82
Is primary nonfunction still a suitable indication for liver retransplantation? 80
Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients 79
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 79
Pancreatic function assessment 79
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation 78
Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation 78
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 77
Can the Rank of Survival Benefit Be Used as a Priority Allocation System in an European Liver Transplant Waiting List? Evidences from an Italian Multicentre Cohort Study 77
Primary difunction after liver trasplantation: donor or recipients fault? 76
Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival 76
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 76
High intraoperative blood product requirements in liver transplantation: Risk factors and impact on the outcome 76
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 75
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 73
Celiac axis compression syndrome in liver transplantation 73
Pregnancy After Liver Transplant: Neonatal Outcomes and Long-Term Maternal Follow-up 73
Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it? 72
Results of liver transplantation for hepatitis delta disease without immunoprophylaxis 72
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 71
Acute decompensation and absence of brain and kidney dysfunction predict long-term efficacy of plasma exchange in hyper-bilirubinemic cirrhotic patients awaiting liver transplantation 69
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 69
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter Italian study 69
Should retransplantation still be considered for primary non-function after liver transplantation? 68
Liver Transplantation in Patients with Alcoholic Liver Disease: A Retrospective Study 68
Alpha-fetoprotein and modified response evaluation criteria in solid tumors progression after locoregional therapy as predictors of hepatocellular cancer recurrence and death after transplantation 67
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 67
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 66
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 66
Effect of liver transplantation on intestinal permeability and correlation with infection episodes 66
Preoperative recipient data and immunosuppression levels are predictive of early patient survival after liver transplantation 65
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient 65
CONUT Score Predicts Early Morbidity After Liver Transplantation: A Collaborative Study 64
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis 64
Totale 9.986
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020279 0 0 0 0 0 0 0 0 0 0 150 129
2020/20211.210 80 125 16 120 177 53 136 19 145 76 239 24
2021/20221.440 84 185 28 104 70 47 10 257 61 83 196 315
2022/20232.789 319 361 258 432 180 360 148 207 305 70 119 30
2023/20241.347 54 426 39 146 58 176 89 43 16 48 127 125
2024/20251.833 44 78 235 113 275 79 79 143 466 307 14 0
Totale 12.780